Literature DB >> 14980387

Glutamate-induced homocysteic acid release from astrocytes: possible implication in glia-neuron signaling.

B Benz1, G Grima, K Q Do.   

Abstract

Glial cells synthesise neuroactive substances and release them upon neurotransmitter receptor activation. Homocysteic acid (HCA), an endogenous agonist for glutamatergic N-methyl-D-aspartate (NMDA) receptors, is predominantly localised in glial cells. We have previously demonstrated the release of HCA from mouse astrocytes in culture following activation of beta-adrenergic receptors. Moreover, a release of HCA has also been observed in vivo upon physiological stimulation of sensory afferents in the thalamus. Here we report the glutamate-induced release of HCA from astrocytes. The effect of glutamate was mediated by the activation of ionotropic (NMDA and non-NMDA) as well as by metabotropic receptors. In addition, the release of HCA was Ca(2+)- and Na(+)-dependent, and its mechanism involved the activation of the Na+/Ca(2+)-exchanger. Furthermore, we provide evidence for the presence of functional NMDA receptors on astrocytes, which are coupled to an intracellular Ca2+ increase via stimulation of the Na+/Ca(2+)-exchanger. Our data thus favour a participation of glial cells in excitatory neurotransmission and corroborate the role of HCA as a "gliotransmitter."

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980387     DOI: 10.1016/j.neuroscience.2003.08.067

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats.

Authors:  Sébastien A Blaise; Emmanuelle Nédélec; Henri Schroeder; Jean-Marc Alberto; Carine Bossenmeyer-Pourié; Jean-Louis Guéant; Jean-Luc Daval
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 2.  Homocysteine and Gliotoxicity.

Authors:  Angela T S Wyse; Larissa Daniele Bobermin; Tiago Marcon Dos Santos; André Quincozes-Santos
Journal:  Neurotox Res       Date:  2021-03-30       Impact factor: 3.911

Review 3.  Glial modulators as potential treatments of psychostimulant abuse.

Authors:  Patrick M Beardsley; Kurt F Hauser
Journal:  Adv Pharmacol       Date:  2014

4.  Investigation of a calcium-responsive contrast agent in cellular model systems: feasibility for use as a smart molecular probe in functional MRI.

Authors:  Goran Angelovski; Sven Gottschalk; Milena Milošević; Jörn Engelmann; Gisela E Hagberg; Pascal Kadjane; Pavle Andjus; Nikos K Logothetis
Journal:  ACS Chem Neurosci       Date:  2014-04-08       Impact factor: 4.418

5.  The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.

Authors:  Patrick M Beardsley; Keith L Shelton; Elizabeth Hendrick; Kirk W Johnson
Journal:  Eur J Pharmacol       Date:  2010-04-23       Impact factor: 4.432

6.  Plasma homocysteine levels in multiple sclerosis.

Authors:  G S M Ramsaransing; M R Fokkema; A Teelken; A V Arutjunyan; M Koch; J De Keyser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 7.  The trinity of Ca2+ sources for the exocytotic glutamate release from astrocytes.

Authors:  Reno C Reyes; Vladimir Parpura
Journal:  Neurochem Int       Date:  2009-01-08       Impact factor: 3.921

8.  Homeostatic function of astrocytes: Ca(2+) and Na(+) signalling.

Authors:  Vladimir Parpura; Alexei Verkhratsky
Journal:  Transl Neurosci       Date:  2012-12       Impact factor: 1.757

9.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

10.  Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase.

Authors:  S E Montoya; E Thiels; J P Card; J S Lazo
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.